Prevalence of metabolic syndrome, insulin resistance, and microvascular angina pectoris in 500 consecutive patients referred to coronarography

Endocrine Regulations

Volumn 46, Issue 1, 2012, Pages 33-38

  Hrnciar, J ^a   Avdicova, M ^a   Gabor, D ^a   Hrnciarova, M ^a   Chamulova, M ^a   Jakubikova, K ^a   Kaliska, G ^a   Kikova, V ^a   Kovar, F ^a   Kreze, A ^a   Lepej, J ^a   Okapcova, J ^a   Szentivanyi, M ^a  

^a Fakultna nemocnica s poliklinikou FD Roosevelta Banska Bystrica   (Slovakia)

Author keywords

Coronary symptoms; Hormones; Insulin resistance; Lipids; Metabolic syndrome

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C PEPTIDE; ENDOTHELIN 1; FIBRINOGEN; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ABDOMINAL OBESITY; ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CORONARY ARTERY OBSTRUCTION; DYSGLYCEMIA; DYSLIPOPROTEINEMIA; ECHOCARDIOGRAPHY; ERGOMETRY; FEMALE; HIRSUTISM; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE;

EID: 84875307172     PISSN: 12100668     EISSN: 13360329     Source Type: Journal    
DOI: 10.4149/endo_2013_01_33     Document Type: Article

References (28)

1. Alexander CM, Landsman PB, Teutsch SM, Hafner SM; NHANES III; NCEP: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52, 1210-1214, 2003. http://dx.doi.org/10.2337/diabetes.52.5.1210
2. Arnlov J, Ingelsson E, Sundstrom J, Lind L: Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 121, 230-236, 2010. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.887521
3. Bairey Merz CN, Pepine CJ: Syndrome X and microvascular coronary dysfunction. Circulation 124, 1477-1480, 2011. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.974212
4. Bougiardini R, Bairey Merz CN: Angina with "normal"coronary arteries. A changing philosophy. JAMA 293, 477-484, 2005. http://dx.doi.org/10.1001/jama.293.4.477
5. Casals-Casas C, Desvergne B: Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 73, 135162, 2011. http://dx.doi.org/10.1146/annurev-physiol-012110-142200
6. Chantal J, Vernay M, Salanave B, Deschamps V, Malon A, Oleko A, Hercberg S, Castetbon K: Nutrition patterns and metabolic syndrome: A need for action in young adults (French Nutrition and Health Survey - ENNS, 2006-2007). Prev Med 51, 488-493, 2010. http://dx.doi.org/10.1016/j.ypmed.2010.09.009
7. Chateau-Degat ML, Dewailly E, Poirier P, Gingras S, Egeland GM: Comparison of diagnostic criteria of the metabolic syndrome in 3 ethnic groups of Canada. Metabolism 57, 1526-1532, 2008. http://dx.doi.org/10.1016/j.metabol.2008.06.006
8. Erem C, Hacihasanoglu A, Deger O, Topbas M, Hosver I, Ersoz HO, Can G: Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocrine 33, 9-20, 2008. http://dx.doi.org/10.1007/s12020-008-9044-3
9. Esteghamati A, Ashraf H, Esteghamati AR, Meysamie A, Khalilzadeh O, Nakhjavani M, Abbasi M: Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: Te implication of metabolic syndrome to detect insulin resistance. Diabetes Res Clin Pract 84, 279-287, 2009. http://dx.doi.org/10.1016/j. diabres.2009.03.005
10. Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27, 2444-2449, 2004. http://dx.doi.org/10.2337/diacare.27.10.2444
11. Grun F, Blumberg B: Endocrine disrupters as obesogens. Mol Cell Endocrinol 304, 19-29, 2009. http://dx.doi.org/10.1016/j. mce.2009.02.018
12. Kaess BM, Pedley A, Massaro JM, Murabito J, Hofmann U, Fox CS: Te ratio of visceral tosubcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia 55, 2622-2630, 2012. http://dx.doi.org/10.1007/s00125-012-2639-5
13. Karelis AD, Faraj M, Bastard J P, St-Pierre DH, Brochu M, Prudhomme D, Rabasa-Lhoret R: Te metabolically healthy but obese individual presents a favorable infammation profle. J Clin Endocrinol Metab 90, 4145-4150, 2005. http://dx.doi.org/10.1210/jc.2005-0482
14. Kothawade K, Bairey Merz CN: Microvascular coronary dysfunction in women-pathophysiology, diagnosis and management. Curr Probl Cardiol 36, 291-318, 2011.
15. Kwasniewska M, Kaczmarczyk-Chalas K, Pikala M, Broda G, Kozakiewicz K, Pajak A, Tykarski A, Zdrojewski T, Drygas W: Commuting physical activity and prevalence of metabolic disorders in Poland. Prev Med 51, 482-487, 2010. http://dx.doi.org/10.1016/j.ypmed.2010.09.003
16. Lee HS, Lee JC, Lee IK, Moon HB, Chang YS, Jacobs DR Jr, Lee DH: Associations among organochlorine pesticides, methanobacteriales and obesity in Korean women. PLoS One 6:e27773, 2011. http://dx.doi.org/10.1371/journal. pone.0027773
17. Lee DH, Lind L, Jacobs DR Jr, Salihovic S, van Bavel B, Lind PM: Associations of persistent organic pollutants with abdominal obesity in the elderly: Te prospective investigation of the vasculature in Uppsala seniors (PIVUS) study. Environ Int 40, 170-178, 2012. http://dx.doi.org/10.1016/j.envint.2011.07.010
18. Legro RS: Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 24, 302-312, 2003. http://dx.doi.org/10.1210/er.2003-0004
19. Rezg R, Mornagui B, El-Fazaa S, Gharbi N: Organophosphorus pesticides as food chain contaminants and type 2 diabetes: A review. Trends Food Sci Technol 21, 345-357, 2010. http://dx.doi.org/10.1016/j.tifs.2010.04.006
20. Riediger ND, Clara I: Prevalence of metabolic syndrome in the Canadian adult population. CMAJ 183, E1127-1134, 2011. http://dx.doi.org/10.1503/cmaj.110070
21. Ronn M, Lind L, van Bavel B, Salihovic S, Michaelsson K, Lind PM: Circulating levels of persistent organic pollutants associate in divergent ways to fat mass measured by DXA in humans. Chemosphere 85, 335-343, 2011. http://dx.doi.org/10.1016/j.chemosphere.2011.06.095
22. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop groups: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19, 41-47, 2004. http://dx.doi.org/10.1093/humrep/deh098
23. Schwartz L, Bourassa MG: Evaluation of patients with chest pain and normal coronary angiograms. Arch Intern Med 161, 1825-1833, 2001. http://dx.doi.org/10.1001/archinte.161.15.1825
24. Serne EH, Stehouwer CD, ter Maaten JC, ter Wee PH, Rauwerda JA, Donker AJ, Gans RO: Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 99, 896-902, 1999. http://dx.doi.org/10.1161/01.CIR.99.7.896
25. Sims EA: Are there persons who are obese, but metabolically healthy? Metabolism 50, 1499-1504, 2001. http://dx.doi. org/10.1053/meta.2001.27213
26. Tanaka T, Morita A, Kato M, Hirai T, Mizoue T, Terauchi y, Watanabe S, Noda M; SCOP Study Group: Congener-specific polychlorinated biphenyls and the prevalence of diabetes in the Saku Control Obesity Program (SCOP). Endocr J 58, 589-596, 2011. http://dx.doi.org/10.1507/endocrj.K10E-361
27. Valvi D, Mendez MA, Martinez D, Grimalt JO, Torrent M, Sunyer J, Vrijheid M: Prenatal concentrations of polychlorinated biphenyls, DDE, and DDT and overweight in children: a prospective birth cohort study. Environ Health Perspect 120, 451-457, 2012. http://dx.doi.org/10.1289/ehp.1103862
28. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB: Abdominal obesity and the risk of all-cause,cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 117, 1658-1667, 2008. http://dx.doi.org/10.1161/CIRCULATIONAHA.107.739714